Hyun Suk Jung Selected Research

type 1B Usher syndrome

7/2015	Structure and Regulation of the Movement of Human Myosin VIIA.
5/2009	The tail binds to the head-neck domain, inhibiting ATPase activity of myosin VIIA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyun Suk Jung Research Topics

Disease

20	Neoplasms (Cancer) 06/2022 - 06/2009
7	Inflammation (Inflammations) 01/2021 - 11/2013
5	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 06/2009
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
4	Testicular Neoplasms (Testicular Cancer) 01/2021 - 01/2018
4	Leukemia 01/2021 - 01/2019
3	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2018
3	Anaphylaxis (Anaphylactic Shock) 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2021 - 01/2020
2	Carcinogenesis 09/2019 - 01/2019
2	Lung Neoplasms (Lung Cancer) 09/2019 - 01/2018
2	Fibrosis (Cirrhosis) 01/2019 - 01/2019
2	Dehydration (Water Stress) 11/2018 - 02/2005
2	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 12/2013
2	type 1B Usher syndrome 07/2015 - 05/2009
2	Neoplasm Metastasis (Metastasis) 04/2012 - 06/2009
1	Infections 09/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Rupture 04/2020
1	Hypoxia (Hypoxemia) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Insect Bites and Stings (Insect Bite) 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 09/2019
1	Huntington Disease (Huntington's Disease) 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018
1	Infarction (Infarctions) 02/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Hyperthermia 12/2017

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 01/2021 - 01/2018
7	Pharmaceutical PreparationsIBA 09/2021 - 12/2017
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2013
4	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2018
3	CytokinesIBA 01/2018 - 12/2012
2	Glycine-tRNA LigaseIBA 01/2022 - 11/2020
2	LigandsIBA 12/2021 - 01/2018
2	dinitrophenyl-human serum albumin conjugateIBA 01/2021 - 01/2020
2	TOR Serine-Threonine KinasesIBA 01/2020 - 09/2019
2	Histone Deacetylase InhibitorsIBA 01/2020 - 10/2019
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 09/2019
2	Histones (Histone)IBA 01/2020 - 12/2018
2	Immunoglobulin E (IgE)IBA 10/2019 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019 - 01/2019
2	SiliconesIBA 01/2019 - 01/2019
2	histone deacetylase 3IBA 12/2018 - 01/2018
2	Interleukin-5 (Interleukin 5)IBA 01/2018 - 11/2013
2	Myosin VIIaIBA 07/2015 - 05/2009
2	Interleukin-10 (Interleukin 10)IBA 11/2013 - 12/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2013 - 12/2012
2	Fetal Proteins (Fetoprotein)IBA 02/2013 - 12/2012
2	C-Reactive ProteinIBA 02/2013 - 12/2012
1	fascinIBA 06/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 12/2021
1	enhanced green fluorescent proteinIBA 12/2021
1	Sirolimus (Rapamycin)FDA Link 12/2021
1	Glutathione (Reduced Glutathione)IBA 12/2021
1	LuciferasesIBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Interleukin-27 (Interleukin 27)IBA 01/2021
1	Sirtuin 1IBA 01/2021
1	EnzymesIBA 11/2020
1	Prothrombin (Factor II)IBA 11/2020
1	VimentinIBA 11/2020
1	Insulin-Like PeptidesIBA 11/2020
1	perovskiteIBA 04/2020
1	AntioxidantsIBA 01/2020
1	Serum AlbuminIBA 01/2020
1	CaspasesIBA 01/2020
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2020
1	DinitrofluorobenzeneIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	HomoharringtonineIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Proto-Oncogene Proteins B-rafIBA 01/2020
1	IgE Receptors (Fc epsilon RI)IBA 10/2019
1	AllergensIBA 10/2019
1	ErbB Receptors (EGF Receptor)IBA 09/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	AntibodiesIBA 09/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2019
1	Biological ProductsIBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2018
1	Beclin-1IBA 01/2018
1	ChemokinesIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Chemokine CXCL2IBA 01/2018
1	Hexosaminidases (Hexosaminidase)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	Contrast MediaIBA 12/2017

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2019
1	Ligation 12/2021